Patient-Focused Drug Development for Mitochondrial Disease
Time: 3:30 pm
day: Day Two
Details:
- Highlighting the impact of patient input on research and development at Abliva
- Providing an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva
- Presenting placebo controlled PMD patient data from our lead asset, KL1333
